Annual Cash & Cash Equivalents:
$191.66M+$2.14M(+1.13%)Summary
- As of today, CLBT annual cash & cash equivalents is $191.66 million, with the most recent change of +$2.14 million (+1.13%) on December 31, 2024.
- During the last 3 years, CLBT annual cash & cash equivalents has risen by +$45.69 million (+31.30%).
- CLBT annual cash & cash equivalents is now at all-time high.
Performance
CLBT Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$525.71M+$53.53M(+11.34%)Summary
- As of today, CLBT quarterly cash & cash equivalents is $525.71 million, with the most recent change of +$53.53 million (+11.34%) on September 30, 2025.
- Over the past year, CLBT quarterly cash & cash equivalents has increased by +$154.95 million (+41.79%).
- CLBT quarterly cash & cash equivalents is now at all-time high.
Performance
CLBT Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CLBT Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +1.1% | +41.8% |
| 3Y3 Years | +31.3% | +258.8% |
| 5Y5 Years | +150.4% | +10000.0% |
CLBT Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +118.7% | at high | +258.8% |
| 5Y | 5-Year | at high | +150.4% | at high | >+9999.0% |
| All-Time | All-Time | at high | +150.4% | at high | >+9999.0% |
CLBT Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $525.71M(+11.3%) |
| Jun 2025 | - | $472.18M(+15.3%) |
| Mar 2025 | - | $409.49M(-8.4%) |
| Dec 2024 | $191.66M(+1.1%) | $447.22M(+20.6%) |
| Sep 2024 | - | $370.76M(+21.4%) |
| Jun 2024 | - | $305.31M(+10.4%) |
| Mar 2024 | - | $276.55M(-8.7%) |
| Dec 2023 | $189.52M(+116.2%) | $302.92M(+14.9%) |
| Sep 2023 | - | $263.74M(+11.2%) |
| Jun 2023 | - | $237.26M(+17.1%) |
| Mar 2023 | - | $202.65M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $87.64M(-40.0%) | $183.62M(+25.3%) |
| Sep 2022 | - | $146.54M(+4.7%) |
| Jun 2022 | - | $140.01M(-15.6%) |
| Mar 2022 | - | $165.93M(-8.6%) |
| Dec 2021 | $145.97M(+13.4%) | $181.56M(+5.8%) |
| Sep 2021 | - | $171.69M(>+9900.0%) |
| Jun 2021 | - | $865.70K(-27.5%) |
| Mar 2021 | - | $1.19M(-99.5%) |
| Dec 2020 | $128.71M(+68.1%) | $242.77M(>+9900.0%) |
| Sep 2020 | - | $1.99M |
| Dec 2019 | $76.55M | - |
FAQ
- What is Cellebrite DI Ltd. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Cellebrite DI Ltd.?
- What is Cellebrite DI Ltd. annual cash & cash equivalents year-on-year change?
- What is Cellebrite DI Ltd. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Cellebrite DI Ltd.?
- What is Cellebrite DI Ltd. quarterly cash & cash equivalents year-on-year change?
What is Cellebrite DI Ltd. annual cash & cash equivalents?
The current annual cash & cash equivalents of CLBT is $191.66M
What is the all-time high annual cash & cash equivalents for Cellebrite DI Ltd.?
Cellebrite DI Ltd. all-time high annual cash & cash equivalents is $191.66M
What is Cellebrite DI Ltd. annual cash & cash equivalents year-on-year change?
Over the past year, CLBT annual cash & cash equivalents has changed by +$2.14M (+1.13%)
What is Cellebrite DI Ltd. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CLBT is $525.71M
What is the all-time high quarterly cash & cash equivalents for Cellebrite DI Ltd.?
Cellebrite DI Ltd. all-time high quarterly cash & cash equivalents is $525.71M
What is Cellebrite DI Ltd. quarterly cash & cash equivalents year-on-year change?
Over the past year, CLBT quarterly cash & cash equivalents has changed by +$154.95M (+41.79%)